做多
EVOK - MA200 Holding - Momentum Increasing
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.
SHORT INTEREST
585.77K 09/13/19
P/E Current
-1.80
P/E Ratio (with extraordinary items)
-2.60
Average Recommendation: HOLD
Average Target Price: 9.00
SHORT INTEREST
585.77K 09/13/19
P/E Current
-1.80
P/E Ratio (with extraordinary items)
-2.60
Average Recommendation: HOLD
Average Target Price: 9.00
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。